To further validate the findings described above, the regulatory effects of iASPP(295–828) on apoptosis were also examined in the breast cancer cell line SK-BR3, in which NF-κBp65 has been reported to be constitutively active and p53 has been inactivated by mutation [31, 32]. This evidence concerns the gene PPP1R13L and breast cancer.